Clinical trial
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit…
NCT00500188 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00500188 |
|---|---|
| Title | Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST |
| Official title | A Prospective, Randomized, Phase II Study of Preoperative Plus Postoperative Imatinib Mesylate (Gleevec, Formerly STI-571) in Patients With Primary, Recurrent, or Metastatic Resectable, Kit-Expressing, Gastrointestinal Stromal Tumor (GIST) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumors |
| Intervention type | Drug |
| Interventions | Imatinib Mesylate (Gleevec) |
| Enrollment | 28 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Jul 12, 2007 |
| Last update posted | Aug 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: